|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 3, 1043-1057, March 2003
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724
Submitted October 19, 2002; Revised November 9, 2002; Accepted November 22, 2002| |
ABSTRACT |
|---|
|
|
|---|
In eukaryotic cells, RNA polymerase II (RNA pol II) transcription and pre-mRNA processing are coordinated events. We have addressed how individual components of the transcription and pre-mRNA processing machinery are organized during mitosis and subsequently recruited into the newly formed daughter nuclei. Interestingly, localization studies of numerous RNA pol II transcription and pre-mRNA processing factors revealed a nonrandom and sequential entry of these factors into daughter nuclei after nuclear envelope/lamina formation. The initiation competent form of RNA pol II and general transcription factors appeared in the daughter nuclei simultaneously, but prior to pre-mRNA processing factors, whereas the elongation competent form of RNA pol II was detected even later. The differential entry of these factors rules out the possibility that they are transported as a unitary complex. Telophase nuclei were competent for transcription and pre-mRNA splicing concomitant with the initial entry of the respective factors. In addition, our results revealed a low turnover rate of transcription and pre-mRNA splicing factors during mitosis. We provide evidence to support a model in which the entry of the RNA pol II gene expression machinery into newly forming daughter nuclei is a staged and ordered process.
| |
INTRODUCTION |
|---|
|
|
|---|
In eukaryotic cells, RNA polymerase II (RNA pol II) transcription
and pre-mRNA processing are coordinated events that require finely
tuned interactions among a large number of proteins (Misteli and
Spector, 1999
; Maniatis and Reed, 2002
; Orphanides and Reinberg, 2002
;
Proudfoot et al., 2002
). One fundamental feature of
mammalian cell nuclei is that many components of the RNA synthesis and
processing machinery are organized into compartments (Spector, 1993
;
Lamond and Earnshaw, 1998
; Misteli, 2000
; Spector, 2001
;
Hernandez-Verdun et al., 2002
; Huang, 2002
). The best
characterized nuclear compartment is the nucleolus where rRNA synthesis
and processing as well as preribosome assembly takes place (Scheer and
Hock, 1999
; Hernandez-Verdun et al., 2002
; Huang, 2002
). The
nucleus is further divided into other nonmembrane-enclosed
compartments, including but not limited to chromosome territories,
nuclear speckles, Cajal bodies, promyelocytic leukemia bodies,
etc. (Spector, 1993
, 2001
; Lamond and Earnshaw, 1998
; Gall, 2000
).
Active transcription sites can be visualized by bromouridine
triphosphate (bromo-UTP) incorporation as several thousand foci
scattered throughout the nucleus that colocalize with transcription
factors, heterogeneous nuclear RNA-associated proteins (hnRNPs), and
other RNA processing factors (Iborra et al., 1996
; Pombo
et al., 2000
). However, these sites are not generally coincident with the larger and less abundant "nuclear speckles" where splicing factors are enriched. Mammalian interphase nuclei typically contain 20-50 nuclear speckles. By electron microscopy, the
speckled pattern corresponds to interchromatin granule clusters (IGCs)
and perichromatin fibrils (Spector et al., 1983
, 1991
; Fakan
et al., 1984
; Fakan, 1994
). Each IG cluster is composed of
granules measuring 20-25 nm in diameter (Fakan and Puvion, 1980
;
Spector, 1993
). Biochemical purification of IGCs from mouse liver
nuclei revealed that IGCs contain ~136 proteins (Mintz et al., 1999
), a large number of which are pre-mRNA processing
factors. IGCs also contain transcription factors (Larsson et
al., 1995
), a hyperphosphorylated form of RNA pol II (Bregman
et al., 1995
), and 3'-processing factors (Schul et
al., 1998
; Calado and Carmo-Fonseca, 2000
). Observations that
splicing factors are recruited from IGCs to transcription sites support
the possibility that one function of IGCs is the assembly/modification
of spliceosomal components (Jiménez-Garcia and Spector, 1993
;
Spector, 1993
; Misteli et al., 1997
; Lamond and Earnshaw,
1998
). Recent results further point to the involvement of IGCs in
coordinating transcription and pre-mRNA splicing (Misteli and Spector,
1999
; Sacco-Bubulya and Spector, 2002
).
On transcriptional elongation, pre-mRNA processing events are typically
initiated immediately, at the site of transcription (Beyer and Osheim,
1988
; Bauren and Wieslander, 1994
; Proudfoot et al., 2002
).
The efficient processing of nascent pre-mRNA is crucial for mRNA
biogenesis and is also a prerequisite for the export of processed mRNA
to the cytoplasm (Custodio et al., 1999
; Reed and Hurt,
2002
). Numerous in vivo and in vitro studies indicate that RNA pol II
couples transcription and pre-mRNA splicing (Hirose and Manley, 2000
;
Maniatis and Reed, 2002
; Proudfoot et al., 2002
). Various
biochemical studies have established that the largest subunit of RNA
pol II shows differential hyperphosphorylation on serine residues
within heptad repeats in its carboxyl-terminal domain (CTD). These
modifications regulate its ability to initiate and elongate transcripts
(Bensaude et al., 1999
; Hirose and Manley, 2000
; Komarnitsky
et al., 2000
) and to interact with specific components of
the RNA processing machinery such as capping enzyme, various splicing
factors, and 3'-end cleavage factors (Kim et al., 1997
;
McCracken et al., 1997
; Ho and Shuman, 1999
; Misteli and
Spector, 1999
; Komarnitsky et al., 2000
; Ryan et
al., 2002
).
In higher eukaryotes, mitosis is accompanied by dramatic
transformations in the structural organization of both the cytoplasm and nucleus. The onset of mitosis is accompanied by chromatin condensation, breakdown of the nuclear envelope (John and Workman, 1998
), and cessation of bulk cellular transcription (Prescott and
Bender, 1962
; Johnson and Holland, 1965
; Gottesfeld and Forbes, 1997
).
The constituents of many nuclear domains, such as the pre-mRNA processing factors in nuclear speckles, become distributed diffusely throughout the cytoplasm (Reuter et al., 1985
; Spector and
Smith, 1986
; Spector et al., 1991
; Ferreira et
al., 1994
). During metaphase, pre-mRNA processing factors begin to
reassemble into discrete structures called mitotic interchromatin
granules (MIGs) (Verheijen et al., 1986
; Leser et
al., 1989
; Ferreira et al., 1994
). MIGs seem to be
structurally analogous to IGCs (Leser et al., 1989
; Thiry,
1993
, 1995a
), and the number and size of MIGs increase progressively
from metaphase to telophase. However, the function of MIGs has not been addressed.
The gene expression machinery must be rapidly reactivated when cells exit from mitosis. Because the onset of transcription in newly formed daughter nuclei relies on the presence of transcription and RNA processing factors, it is important to determine when the bulk of these factors reenter daughter nuclei and whether factors are recycled or are newly translated at the end of mitosis. Herein, we report on the localization and stability of transcription and pre-mRNA processing factors during the mitosis/G1 transition. We found that RNA pol II and its transcription and pre-mRNA processing factors entered daughter nuclei in a sequential and nonrandom manner after nuclear envelope/lamina formation. Bromo-UTP incorporation was temporally correlated with the presence of the initiation-competent form of RNA pol II in daughter nuclei, and it was further enhanced with increased accumulation of the elongation-competent form of RNA pol II. The pre-mRNA processing machinery appeared in daughter nuclei after the entry of the general transcription factors but just before the appearance of the elongation competent form of RNA pol II. Interestingly, transcription and pre-mRNA processing factors had a low turnover rate during mitosis and were recycled from the cytoplasm into daughter nuclei. Our data demonstrate that nuclear entry of the RNA pol II gene expression machinery after mitosis is a staged process whereby the transcription apparatus enters in a separate and reproducible window of time prior to the entry of the pre-mRNA processing machinery.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
cDNA Constructs
Polymerase chain reaction generated a restriction site at the
stop codon of human SC35 cDNA for convenient subcloning into pEYFP-N1
(BD Biosciences Clontech, Palo Alto, CA). SF2/ASF was subcloned from
GFP-SF2/ASF vector (Misteli et al., 1997
) into the
corresponding pEYFP vector.
Cell Culture and Transfection
HeLa cells were grown in DMEM containing low glucose (Invitrogen, Carlsbad, CA) supplemented with penicillin-streptomycin and 10% fetal bovine serum (Hyclone Laboratories, Logan, UT). Electroporation was performed on trypsinized cells resuspended in 250 µl of growth medium and transferred to cuvettes containing 2 µg of fusion protein plasmid plus 20 µg of salmon sperm DNA. Cells were seeded onto acid-washed coverslips and processed for immunofluorescence localization of nuclear speckle proteins 2 d after transfection.
Cell Synchronization and Drug Treatments
To obtain large numbers of mitotic cells for protein turnover studies (Figure 9), HeLa cells were arrested at prometaphase with 50 ng/ml nocodazole for 14-18 h. Cells were treated with or without cycloheximide 50 µg/ml during the final 30 min of nocodazole treatment. Prometaphase cells were collected and were continuously incubated in medium either with or without (control) cycloheximide during release from mitosis. Cells were incubated with [35S]methionine (10 mCi/ml) in cold methionine-free medium for 30 min before collection. Aliquots of cells were collected at the indicated times (as in text) and the efficacy of the protein synthesis block was analyzed by measuring incorporated [35S]methionine by autoradiography. Parallel samples were also analyzed by immunoblotting, fluorescence-activated cell sorting (FACS), and immunofluorescence.
Immunofluorescence
Cells were rinsed briefly in phosphate-buffered saline (PBS) and
then fixed for 15 min in 1.7% formaldehyde in PBS (pH 7.4) or for 5 min in cold methanol (
20°C) for optimal penetration of IgM
antibodies into nuclei. Cells were permeabilized in PBS containing
0.5% Triton X-100 and 1% goat serum for 7-10 min on ice, and primary
antibodies were added for 1 h at room temperature: anti-RNA pol II
(8WG16 [1:200], H14 [1:20], H5 [1:20], hnRNP A1 [1:1500], hnRNP
C1/C2 [1:2500], p56 [TFIIE subunit] [1:50], TFIIB [1:300],
TFIIF [RAP74; 1:300], TFIIH [ERCC2, 1:200; ERCC3, 1:100], DRIP130
[1:500], DRIP150 [1:300], TATA binding protein [TBP] [1:50], CstF-64 [1:50], SC35 [1:200], 4G3 anti-B" [1:100], mAb103
anti-SF2/ASF [1:50], SF3a-60 [1:800], lamin B1 [1:500], lamin A/C
[1:500], p62 [nuclear pore protein] [1:100], poly (A) binding
protein II [PABP II] [1:200], m3G anti-snRNA
[1:50], ubiquitin [1:1500]). Cells were rinsed in PBS containing
1% goat serum and then secondary anti-species-specific antibodies
(Jackson Immunoresearch Laboratories, West Grove, PA) were added for 30 min at room temperature: goat anti-mouse (GAM) IgG1-Texas Red (1:1000),
GAM IgG H+L Texas Red (1:500), GAM IgM-Cy5 (1:1000), goat anti-rat
IgG-fluorescein (1:1200). DNA was stained with
4,6-diamidino-2-phenylindole (DAPI). Cells were mounted in medium
containing 90% glycerol, 10% PBS pH 8.0 plus 1 mg/ml
paraphenylenediamine. Cells were examined using an Axioplan 2i
fluorescence microscope (Carl Zeiss, Thornwood, NY) equipped with
Chroma filters (Chroma Technology, Brattleboro, VT). OpenLab software
(Improvision, Boston, MA) was used to collect digital images from a
ORCA cooled charge-coupled device camera (Hamamatsu, Bridgewater, NJ).
Bromo-UTP Incorporation
HeLa cells were rinsed briefly in glycerol buffer (20 mM Tris-HCl pH 7.4, 5.0 mM MgCl2, 25% glycerol, 0.5 mM phenylmethylsulfonyl fluoride, and 0.5 mM EGTA) followed by permeabilization for 3 min in glycerol buffer supplemented with 2 µg/ml digitonin. Transcription buffer (100 mM KCl, 50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 0.5 mM EGTA, 25% glycerol, 1.0 mM phenylmethylsulfonyl fluoride, 2.0 mM ATP, 0.5 mM GTP, 0.5 mM CTP, 0.2 mM 5-bromo-UTP, and 1.0 µg/ml RNAsin) was added for 5 min at 37°C. Colocalization of bromo-UTP (rat anti-bromo, 1:30) and splicing factors was performed as described above.
RNA Fluorescence In Situ Hybridization
To detect splicing of
-tropomyosin minigene pre-mRNA, a
24-mer oligodeoxynucleotide conjugated with a single Texas Red molecule at the 5' end (Invitrogen) was designed to hybridize to the splice junction between exons 5 and 6 (5'-tgcctggctcggctctcagccacc-3'). Control 12-mer oligos were designed to hybridize to the 3' end of exon
5 (5'-tgcctggctcgg-3') or the 5' end of exon 6 (5'-ctctcagccacc-3'). Cells were extracted in CSK buffer (100 mM NaCl, 300 mM sucrose, 3 mM
MgCl2, and 10 mM PIPES pH 6.8) supplemented with
0.5% Triton X-100 and 2 mM vanadyl ribonucleoside complex. After
immunolabeling as described above, cells were again fixed for 15 min in
2% formaldehyde. Hybridization of oligo probes (1 ng/µl) was
performed in 35% deionized formamide, 10% dextran sulfate, 1 mg/ml
yeast tRNA, and 2× SSC for 3 h at 37°C. Cells were washed for
30 min in 25% formamide/2× SSC at 37°C and then 30 min in 2× SSC.
Cells were mounted and images obtained using an Axioplan
2i-fluorescence microscope (Carl Zeiss) equipped with Chroma filters
(Chroma Technology) as described above.
Live Cell Microscopy
HeLa cells were transiently transfected with 2 µg of YFP-SF2/ASF or SC35-YFP and live-cell observations were initiated 2 d posttransfection to ensure that fusion protein would be detectable in mitotic cells. The cells were transferred to an FCS2 live-cell chamber (Bioptechs, Butler, PA) mounted onto the stage of an IX70 inverted fluorescence microscope (Olympus, Melville, NY) and kept at 37°C in L-15 medium (minus phenol red) containing 10% fetal bovine serum. Time-lapse images acquired with a 100× 1.4 numerical aperture heated objective lens were captured with a Peltier-cooled IMAGO charge-coupled device camera by using an SVGA interline chip (1280 × 1024) with a pixel size of 6.7 µm (Till Photonics, Munich, Germany).
Online Supplemental Materials
Video 1. A HeLa cell in metaphase exhibits a diffuse localization of YFP-SF2/ASF with a few small MIGs near the metaphase plate. On entry into anaphase, the number and size of MIGs increases. As nuclear entry of YFP-SF2/ASF begins, there is a concomitant decrease in YFP-SF2/ASF signal in MIGs, consistent with recycling of splicing factors into newly forming daughter nuclei. Image sequences were acquired using TillVision software (Till Photonics) and animated using QuickTime software. The video is comprised of a sequence of 260 images. Exposures (20 ms) were collected every 15 s for 65 min.
| |
RESULTS |
|---|
|
|
|---|
Components of Transcription and pre-mRNA Processing Machinery Enter Daughter Nuclei after Nuclear Envelope/Lamina Formation
One of the earliest events in establishing daughter nuclei after
mitosis is deposition of the nuclear envelope/lamina around segregated
chromosomes (Haraguchi et al., 2000
; Moir et al.,
2000
; Gerlich et al., 2001
; Goldman et al.,
2002
). To determine whether the bulk of RNA pol II transcription and
pre-mRNA processing factors associate with daughter nuclei before or
after nuclear envelope/lamina formation, we performed
coimmunolocalization experiments with antibodies against various
transcription or RNA processing factors and members of the nuclear
lamina/nuclear pore complex in asynchronous HeLa cells. The largest
subunit of RNA pol II in its hypo- (Figure 1b) as well as hyperphosphorylated
(Figure 1, e and h) forms was predominantly present in the cytoplasm
when lamin B1 (Figure 1, c and f) or nuclear pore complex protein p62
(Figure 1i) had already localized around the periphery of newly forming
daughter nuclei. Similarly, the largest subunit of transcription factor
TFIIE, p56 (Figure 1k), was not yet detectable in daughter nuclei at a
stage when p62 (Figure 1l) or lamin B1 (our unpublished data) had already begun to localize at the nuclear periphery. Lamins A/C also
showed peripheral nuclear staining before the entry of RNA pol II and
general transcription factors (data not shown). Next, we
examined the localization of the B" protein, an integral component of
the U2 small nuclear (sn)RNP complex (Habets et al., 1989
).
In early telophase cells, B" was diffusely distributed in the cytoplasm
as well as enriched in MIGs (Figure 1n, arrow). Similar to RNA pol II
and transcription factors, B" remained in the cytoplasm (Figure 1n),
whereas the nuclear lamina and envelope was assembled (Figure 1o).
Similar observations were made with other pre-mRNA splicing factors,
including SF2/ASF and SF3a-60 (our unpublished data). An
antibody that recognizes the trimethyl guanosine cap of snRNAs (m3G)
also showed positive nuclear staining only after nuclear
envelope/lamina formation occurred (our unpublished data). These
results clearly indicated that nuclear envelope/lamina formation occurs
before nuclear entry of various components of the transcription and
pre-mRNA processing machinery.
|
Initiation-Competent Form of RNA pol II and Its Associated Transcription Factors Appear in Daughter Nuclei prior to Nuclear Entry of pre-mRNA prior to Processing Machinery
Next, we evaluated the sequence of nuclear import of various
components of the gene expression machinery. First, we wanted to
establish the timing of RNA pol II entry with regard to entry of
transcription and pre-mRNA processing factors. Antibody 8WG16 (Thompson
et al., 1989
) predominantly detects the hypophosphorylated form of the large subunit of RNA pol II. Antibody H14 (Bregman et
al., 1995
) recognizes the hyperphosphorylated ser-5 moiety in the
CTD repeats, and preferentially recognizes the form of RNA pol II that
is competent for the initiation of transcription (Komarnitsky et
al., 2000
). Both the 8WG16 and H14 epitopes were simultaneously
detectable in midtelophase daughter nuclei (Figure 2, b and c). However, although there was
a negligible amount of cytoplasmic H14 staining (Figure 2b), there was
a significant level of cytoplasmic 8WG16 staining that persisted until
late telophase/early G1 (Figure 2c). TFIIE entered daughter nuclei at
the same time as RNA pol II (H14; Figure 2, e and f). Similar observations were made with other general transcription factors, including TFIIB, TFIIF (RAP 74) and TFIIH (ERCC2, ERCC3) as well as
components of mediator complex (DRIP 130, 150) (Figure 4). This differs
from the behavior of TBP, a member of the TFIID complex that was found
on the chromosomes throughout mitosis (our unpublished data)
(Chen et al., 2002
). Thus, RNA pol II and multiple
components of the transcription machinery entered daughter nuclei
simultaneously during a narrow temporal window in telophase.
|
We then compared the import of various pre-mRNA processing factors with
respect to entry of the transcription machinery. Interestingly, the
bulk of B" (Figure 2i) and SR splicing factor SF2/ASF (Figure 2l)
remained localized in the cytoplasm of telophase cells, intensely concentrated in the MIGs, even as the ser-5 phosphorylated RNA pol II
appeared in the nucleus (Figure 2, h and k). Similarly, splicing factor
SF3a-60 (Schmidt-Zachmann et al., 1998
) and the snRNAs, as
well as hnRNP C1/C2 (Figure 2o) (Pinol-Roma and Dreyfuss, 1991
), hnRNP
A1, and PABP II entered the daughter nuclei after RNA pol II and
transcription factors (see Figure 4 for details). In contrast, the
cleavage stimulation factor CstF-64 entered the daughter nuclei at the
same time as RNA pol II and transcription factors (Figure 2, q and r).
In summary, the hypo- and ser-5-hyperphosphorylated forms of the large
subunit of RNA pol II and its associated factors, as well as CstF-64
entered the daughter nuclei almost simultaneously, prior to entry of
the bulk of other pre-mRNA processing factors.
Elongation-Competent Form of RNA pol II Appears in Daughter Nuclei after Import of RNA Processing Machinery
Next, we examined the presence in daughter nuclei of the serine-2
phosphorylated form of RNA pol II, which plays an essential role in
transcriptional elongation (Komarnitsky et al., 2000
) and
which is recognized by the H5 antibody (Bregman et al.,
1995
). Ser-2 phosphorylated RNA pol II colocalized with splicing
factors in speckles in interphase nuclei and in the cytoplasmic MIGs in mitotic cells (Bregman et al., 1994
, 1995
). This form of RNA
pol II remained in the cytoplasm (Figure
3, b and e) when hnRNP C1/C2 (Figure 3c)
and hnRNP A1 (Figure 3f) had already appeared in the daughter nuclei.
Splicing factors B" (Figure 3i), SF2/ASF (Figure 3l), and SF3a-60 and
m3G-containing snRNPs (our unpublished data) also appeared in
daughter nuclei before the ser-2 modified form of RNA pol II (Figure 3,
h and k). This result implies that the ser-5 phosphorylated form of RNA
pol II that accumulates in daughter nuclei during midtelophase is not
hyperphosphorylated at the ser-2 moiety until after the pre-mRNA
processing machinery has entered the nuclei (see DISCUSSION).
|
We extended our analysis to monitor the timing of nuclear entry of
splicing factors vs. other pre-mRNA processing factors. A schematic
diagram of the complete analysis summarizing the data is shown in
Figure 4. It was previously shown that
hnRNP C proteins are transported into the daughter nuclei before hnRNP
A1 (Pinol-Roma and Dreyfuss, 1991
). In addition, our results showed
that splicing factors (B", SF2/ASF and SF3a) and snRNPs entered
daughter nuclei after hnRNP C1/C2, but prior to hnRNP A1. However, PABP
II and hnRNP A1 entered almost simultaneously.
|
Transcription Machinery Is Active Immediately upon Nuclear Entry
We were interested in determining whether RNA pol II and
its associated factors immediately begin transcribing RNAs upon entry into daughter nuclei. To visualize the earliest active transcription sites in daughter nuclei, HeLa cells were permeabilized with digitonin and incubated in transcription buffer containing bromo-UTP for 5 min at
37°C. Before appearance of RNA pol II in daughter nuclei (H14
epitope; Figure 5b), transcription was
not detectable (Figure 5c). When RNA pol II (H14 epitope) was first
detectable in daughter nuclei during telophase (Figure 5e), global
transcription was detected by bromo-UTP incorporation as faint,
punctate foci throughout the nuclei (Figure 5f), which likely result
from initiation of transcription by ser-5 phosphorylated RNA pol II.
Daughter nuclei with low levels of elongation-competent RNA pol II (H5;
Figure 5h) showed faint bromo-UTP incorporation in the nucleoplasm, as well as some bright foci (Figure 5i), the latter of which likely correspond to RNA pol I transcription sites in the nucleolar organizing regions. With increased amounts of H5 epitope in daughter nuclei (Figure 5k), bromo-UTP incorporation increased (Figure 5l), consistent with additional initiation and transcript elongation at this stage. The
increase in nuclear H5 signal in late telophase nuclei is probably a
result of the change in hyperphosphorylation (ser-5 to ser-2) of the
CTD of RNA pol II already situated at transcription sites.
|
The pre-mRNA Splicing Machinery Is Recruited to Transcription Sites and Is Functional Immediately upon Nuclear Entry
A HeLa cell line with a stably integrated
-tropomyosin minigene
reporter was used to determine whether splicing factors are competent
for pre-mRNA splicing during late telophase in daughter nuclei. Using
an intron-specific oligonucleotide probe to
-tropomyosin pre-mRNA,
the site of transcription was localized in interphase nuclei by RNA
fluorescent in situ hybridization (Figure
6c, arrows). Splicing factors such as
SF2/ASF are recruited to this transcription site during interphase
(Figure 6b, arrows). We found that the
-tropomyosin pre-mRNA is also
transcribed during late telophase. To determine whether this newly
transcribed pre-mRNA was being spliced at the transcription site we
used a 24-mer splice junction oligonucleotide probe that hybridizes
only to spliced message by virtue of its complementarity to 12 nucleotides at the 3' end of exon 5 and 12 nucleotides at the 5' end of
exon 6. Hybridization of this oligonucleotide in mitotic cells
indicated that splicing factors are competent for intron excision as
early as telophase (Figure 6, f and i, arrows). Furthermore, we could
detect splicing factors such as SF2/ASF (Figure 6e) and B" (Figure 6h)
at the transcription site immediately upon their entry into daughter nuclei, before their significant accumulation in the nucleoplasm and
prior to the formation of nuclear speckles. Importantly, we excluded
the possibility that the splice junction probe partially hybridizes to
pre-mRNA, via either half of this probe, because we did not detect
hybridization of control 12-mer oligonucleotides (Figure 6l) in
telophase cells in regions where SF2/ASF has accumulated (Figure 6k,
arrow) at what likely corresponds to the
-tropomyosin transcription
site.
|
Release of Splicing Factors from MIGs during Telophase Is Concurrent with Their Nuclear Entry
The number and size of cytoplasmic MIGs increases when cells
transit from metaphase to telophase. SF2/ASF in MIGs decreased by late
telophase, the time when SF2/ASF entered the daughter nuclei (compare
Figure 3, l and o). Surprisingly, in the same telophase cells, the
ser-2 phosphorylated form of RNA pol II (labeled by H5) persisted in
the MIGs (compare Figure 3, n and o). Other splicing factors such as
U2-snRNP (detected by B") and m3G-containing snRNPs behaved in a
similar manner as SF2/ASF (our unpublished data). Surprisingly,
immunostaining with an antibody against essential splicing factor SC35
(Fu and Maniatis, 1990
) revealed that it remains in the cytoplasmic
MIGs of telophase cells after all modified forms of RNA pol II
(detected by 8WG16, H14, and H5) and other factors of the gene
expression machinery entered daughter nuclei (our unpublished
data). However, transient transfection of an SC35 cDNA fused to
yellow fluorescent protein (YFP) showed that SC35-YFP entered daughter
nuclei at the same time as other splicing factors (our unpublished
data). The difference in nuclear entry detected using SC35
antibody vs. SC35-YFP fusion protein is likely due to the fact that the
SC35 antibody recognizes a subpopulation of SC35 protein, most likely a
specific modified (i.e., phosphorylated) form that enters at a time
point later than other splicing factors. To confirm that MIGs are not
merely protein degradation sites, cells were immunolabeled with an
antibody against ubiquitinated proteins and no positive labeling of
MIGs was observed (Figure 7). Taken
together, these results indicate that all MIGs have a similar
composition at a given stage of mitosis, and raises the possibility
that different factors are released from MIGs at different time points
and enter daughter nuclei sequentially. To investigate this further,
HeLa cells were transiently transfected with either YFP-SF2/ASF or
SC35-YFP and localization of the fusion protein was monitored in living
mitotic cells by time-lapse microscopy (Figure
8; see video, Mitosis.mov). During
metaphase, YFP-SF2/ASF was localized in a diffuse cytoplasmic pattern
and in addition one to two small MIGs were routinely observed (Figure
8a). As mitosis progressed from late-anaphase to early telophase, the MIGs increased in size and number (Figure 8, b and c). During midtelophase, YFP-SF2/ASF began to enter daughter nuclei (Figure 8d)
and the MIG signal decreased simultaneously (Figure 8, e-h) (see
supplementary movie). The majority of YFP-SF2/ASF protein entered
daughter nuclei within 10 min; however, some faint signal was still
detectable in MIGs. Similar results were seen with SC35-YFP (our
unpublished data). These results raised the possibility that during
telophase, splicing factors are recycled from the cytoplasm (MIGs) into
daughter nuclei.
|
|
RNA Processing Factors Have a Low Turnover Rate during Mitosis
As observed in fixed and living cells, the disappearance of
splicing factors from MIGs was coincident with their appearance in
daughter nuclei, suggesting that cycling was occurring. We pursued this
possibility further by addressing whether the transcription and RNA
processing factors found in the newly formed daughter nuclei were
synthesized just after mitosis, or whether they were recycled from the
preexisting cytoplasmic population. We arrested HeLa cells at
prometaphase with the microtubule disrupting drug nocodazole, and then
subsequently released the cells from mitotic arrest either in the
presence or absence of the protein synthesis inhibitor cycloheximide
(see MATERIALS AND METHODS). Cells were collected over a time course
and total cellular proteins were subjected to SDS-PAGE. The Coomassie
Blue staining (Figure 9a) showed the
level of proteins in each lane and the corresponding [35S]methionine incorporation (Figure 9b)
revealed a complete inhibition of protein synthesis in the cells
incubated with cycloheximide (Figure 9b, lanes 2, 4, and 6). Cell cycle
progression was monitored by assaying the DNA content of propidium
iodide stained cells by FACS (Figure 9c). It was clear that in the
absence of protein synthesis, the majority of cells progressed normally
through the cell cycle and entered G1, as determined by FACS and phase
contrast microscopy (data not shown). Immunoblot
analysis was carried out with the above-mentioned samples by using
antibodies against various splicing factors (SF2/ASF and B"), CstF-64,
hnRNP A1, hnRNP C1/C2, and different forms of RNA pol II (8WG16, H14,
and H5) (Figure 9d). These results showed that there is not a
significant turnover of the components of the pre-mRNA splicing and RNA
processing machinery during mitosis (Figure 9d, lanes 1-4). A similar
low turnover rate was observed for the RNA pol II transcription factors TFIIB and TBP (our unpublished data). Consistent with this finding, the
recruitment of factors into daughter nuclei as observed by immunofluorescence was similar in the presence or absence of
cycloheximide (data not shown). Note that as the cells progressed into
G1, there was a fresh round of protein synthesis as seen by the
quantitative difference in protein levels as detected by immunostaining
after 4 h of release from nocodazole arrest with or without
cycloheximide (Figure 9d, compare SF2/ASF, B", CstF-64, and hnRNP C1/C2
between lanes 5 and 6).
-Tubulin and cyclin A are shown as internal
controls for equal protein loading and cell cycle progression,
respectively. These results conclusively demonstrate that transcription
factors and splicing factors have a low rate of turnover during
mitosis, and it is the preexisting population of proteins that is
recycled into daughter nuclei during the transition from mitosis to G1.
|
| |
DISCUSSION |
|---|
|
|
|---|
A physical coupling between transcription and pre-mRNA processing
components is now thought to be instrumental for efficient gene
expression (Maniatis and Reed, 2002
). During mitosis, there is a global
shut down of gene expression, due at least in part to the
hyperphosphorylation of a large number of proteins involved in this
process and resulting in the disassembly of many cellular structures
(Gottesfeld and Forbes, 1997
). A problem confronted by the mitotic cell
is the establishment of the gene expression machinery in daughter
nuclei so that these cells become competent to undergo
transcription/RNA processing as they exit from mitosis. To investigate
whether components of the gene expression machinery enter the
postmitotic nuclei individually or as a unitary complex, we used
immunofluorescence and live cell imaging to monitor the dynamics of
these factors from mitosis to G1. We have demonstrated that
transcription and pre-mRNA splicing factors enter the nuclei sequentially, not as a unitary complex, after nuclear envelope/lamina formation. This ordered entry of transcription factors prior to pre-mRNA splicing factors seems to be a general phenomenon because we
have observed similar results in transformed cells (HeLa) as well as in
cells of defined passage number (IMR90). Furthermore, we have shown
that telophase nuclei are competent for transcription and pre-mRNA
splicing immediately upon reentry of the gene expression machinery. The
present study also established a low turnover of transcription and
pre-mRNA splicing factors during mitosis demonstrating that the
preexisting population of proteins recycled into daughter nuclei as the
cells progress through telophase.
The nuclear envelope/lamina of higher eukaryotes breaks down during
prophase and is reconstituted around chromosomes during late anaphase
to telophase, reestablishing the boundary of the interphase nucleus
(Haraguchi et al., 2000
; Goldman et al., 2002
). Our observations that import of transcription and pre-mRNA processing factors into daughter nuclei occurs after the nuclear envelope and
lamina are assembled suggests that import occurs through nuclear pore
complexes by active transport, because many of the presently studied
proteins are above the size exclusion for transit by diffusion (Adam,
1999
). Although all the members of the RNA pol II gene expression
machinery do not enter newly formed daughter nuclei as a unitary
complex, we cannot exclude the possibility that groups of some of these
proteins enter as heterotypic complexes. Although the nuclear entry of
these factors coincides with activation of transcription in daughter
nuclei, transcription inhibition does not interfere with entry of most
of these proteins (Ferreira et al., 1994
), with the
exception of hnRNP A1, which is known to be retained in the cytoplasm
of transcriptionally inhibited postmitotic cells (Pinol-Roma and
Dreyfuss, 1991
).
Immunolabeling with specific antibodies that detect the largest subunit
of RNA pol II clearly shows that hypo- and ser-5-phosphorylated RNA
pol II appear in daughter nuclei before the ser-2 phosphorylated form
of RNA pol II. CTD phosphorylation at ser-2 and ser-5 represents an
important regulatory mechanism for coordinating RNA pol II activity
(West and Corden, 1995
; Bensaude et al., 1999
).
Phosphorylation of the CTD occurs soon after initiation of
transcription and is necessary for interaction of RNA pol II with other
RNA processing factors (Hirose and Manley, 2000
). Studies from various
laboratories suggest that RNA pol II with a hypophosphorylated CTD is
preferentially included in the transcription preinitiation complex
formed at the promoter. Once bound to the promoter, the CTD is
phosphorylated at ser-5 and becomes initiation competent (Komarnitsky
et al., 2000
; Cho et al., 2001
). Chromatin
immunoprecipitation studies showed that the phosphorylated ser-5 (H14)
epitope persists until RNA pol II transcribes up to 200 nucleotides
downstream of the promoter, at which time the ser-5 phosphate is either
removed or the CTD is further modified in a way that blocks the H14
epitope (Komarnitsky et al., 2000
). On the other hand, the
ser-2 (H5) epitope was not detected on RNA pol II at the promoter, but
was detected on the polymerase in the coding regions of the genes studied leading to the interpretation that it is the elongation competent form of the polymerase (Komarnitsky et al., 2000
).
Our study revealed that the initiation competent form of RNA pol II appeared in daughter nuclei almost simultaneously with other
transcription factors but before splicing factors. Dual immunostaining
studies with 8WG16 and H14 revealed the concomitant presence of these two forms of RNA pol II in the daughter nuclei. However, we have not
been able to determine whether appearance of the ser-5 (H14) phosphorylated form of RNA pol II in daughter nuclei is a consequence of entry of this modified form from the cytoplasmic population or
whether the unphosphorylated form enters the nucleus and is subsequently phosphorylated. Nocodazole block and release in the presence or absence of cycloheximide showed that the level of all forms
of RNA pol II was constant from M phase to G1. Continuous oscillation
of phosphorylation/dephosphorylation of RNA pol II makes it difficult
to address the issue of recycling of the ser-5 modified form. However,
phosphorylation at ser-5 may occur in daughter nuclei because it is the
hypophosphorylated form of RNA pol II that is preferentially detected
at the preinitiation complex at the promoter (Hirose and Manley, 2000
).
Consistent with this, we observed that a subpopulation of postmitotic
nuclei positive for the ser-5 phosphorylated form of RNA pol II and
other transcription factors showed weak bromo-UTP incorporation,
suggesting that only initiation of transcription was occurring in these
cells at this time point. In support of this possibility, those cells
that showed weak bromo-UTP incorporation also showed weak to no H5
immunolabeling, leading us to speculate that the RNA pol II present in
these nuclei is not the elongation competent form. Furthermore, we
observed that the level of bromo-UTP incorporation increased
dramatically in cells showing intense H5 labeling.
An important question concerning the organization of the gene
expression machinery during cell division concerns the timing of import
of various transcription and RNA processing factors into daughter
nuclei with respect to activation of transcription and splicing in
these cells. Our data demonstrate that the transcription apparatus
reproducibly enters daughter nuclei independently of pre-mRNA splicing
factors, which are recruited into daughter nuclei after transcription
is initiated. Therefore, a mechanism must exist to coordinate
transcription and pre-mRNA splicing during the transition from
telophase to the establishment of the interphase nucleus. Nuclear
speckles have been suggested to play a role in coupling transcription
and pre-mRNA splicing in mammalian interphase nuclei (Misteli and
Spector, 1999
; Sacco-Bubulya and Spector, 2002
). Although MIGs have
been proposed to be the mitotic equivalent of nuclear speckles, their
function in mitotic cells has not been addressed (Leser et
al., 1989
; Thiry, 1995a
,b
). In telophase cells, some MIGs were
found to be in proximity to the newly formed nuclear envelope. This
proximity of MIGs to the nuclear periphery and the disappearance of
MIGs in late telophase cells with the appearance of IGCs in daughter
nuclei have suggested that the MIGs might be directly transported into
the nuclei (Leser et al., 1989
; Thiry, 1995a
,b
). However,
colocalization of SF2/ASF and RNA pol II (H5) in MIGs of late telophase
cells (Figure 3, j-o) clearly shows that various components of MIGs
are differentially released for subsequent entry into the nucleus,
whereas some factors such as modified forms of SC35 and RNA pol II (H5)
still maintain a subpopulation in MIGs until G1. This result raises the
possibility that MIGs might be playing important roles either in
modification of the components of the splicing machinery before their
nuclear entry, or as enriched populations of these factors allowing for
protein-protein interactions to occur between subsets of proteins
before their nuclear entry.
Our data demonstrating that splicing factors are competent for pre-mRNA
splicing immediately upon entry into daughter nuclei supports the
possibility that MIGs may be responsible for splicing factor
modification, allowing for immediate targeting of modified RNA
processing complexes to transcription sites in telophase nuclei. Because daughter nuclei late in telophase have not yet assembled nuclear speckles, cytoplasmic MIGs are likely to function as their counterparts to provide competent pre-mRNA splicing factors to the
initial sites of transcription in newly formed nuclei. Perhaps splicing
factors are released from MIGs via hyperphosphorylation as has been
demonstrated for their release from nuclear speckles in interphase
nuclei. Of particular interest in this regard are two kinase families,
SR protein specific kinases, including SRPK1, 2 and cdc2-like kinases
(Clk/STY 1-4) that have been shown to specifically phosphorylate the
RS domains of SR splicing factors (Howell et al., 1991
;
Colwill et al., 1996a
,b
; Wang et al., 1998a
,b
; Yeakley et al., 1999
). Although Clk/STY has been shown to
modulate the localization of SR proteins in interphase nuclei (Colwill et al., 1996a
,b
; Sacco-Bubulya and Spector, 2002
), SRPK
family has been implicated in the reorganization of splicing factors associated with mitosis (Gui et al., 1994a
,b
). Future
studies will address the role of SRPK or Clk/STY family members in the release of splicing factors from MIGs, thereby making them available to
enter daughter nuclei.
Our study provides two lines of evidence to support recycling of MIG constituents (splicing factors) during mitosis. First, observation of YFP-tagged splicing factors in living cells demonstrates a decrease in the MIG population of splicing factors concomitant with an increase in the nuclear population of these factors. Second, we demonstrate that there is a low turnover rate of protein constituents of the splicing machinery during mitosis, suggesting recycling of a preexisting population into newly formed daughter nuclei. Based upon these observations, we propose a direct role for MIGs in recycling of splicing factors during mitosis. Our data are consistent with the possibility that proteins and/or protein complexes are released from MIGs for subsequent entry into daughter nuclei. Future studies will examine this possibility in living cells.
Our results demonstrating that the entry of RNA pol II, transcription
and pre-mRNA processing factors into postmitotic daughter nuclei is a
staged process that occurs after the deposition of nuclear
envelope/lamina, suggests the existence of a possible regulatory
mechanism, at the level of nuclear import for each class of these
factors, as the cells exit mitosis. Facilitated transport of proteins
into the nucleus requires the presence of signal motifs, nuclear
localization signals (NLSs), which are recognized by specific soluble
shuttling receptors of the importin/karyopherin family (Mattaj and
Englmeier, 1998
; Kuersten et al., 2001
). Nuclear import of
proteins with a classical basic NLS is mediated by the dimeric complex
of importin
/
, of which the importin-
subunit binds to the NLS
directly and serves as the adaptor to importin-
(Jans et
al., 2000
). The importin-
receptor facilitates nuclear translocation by binding to nuclear pore proteins and Ran GTPase in
conjunction with other proteins leading to nuclear import. To date,
many nonprototypical NLSs have been reported (Nakielny and Dreyfuss,
1999
). The well-characterized nonclassical NLS is the M9 sequence of
hnRNP A1 (Siomi and Dreyfuss, 1995
). M9-dependent import is
mediated by transportin 1, which is related to importin-
. Similarly,
the majority of the SR proteins are imported into the nuclei with the
help of two different importins-
, transportin SR1 (TRN-SR1) and
transportin SR2 (TRN-SR2) (Kataoka et al., 1999
; Lai
et al., 2000
). TRN-SR2 mediates the nuclear import of
phosphorylated SR proteins (Lai et al., 2001
; Allemand
et al., 2002
), suggesting that differentially modified
proteins could be imported by independent mechanisms by different
importin receptors (Nakielny and Dreyfuss, 1999
). It is tempting to
speculate that the differential entry of RNA pol II transcription and
pre-mRNA processing factors at the end of mitosis could be the result
of regulated interactions with various importin superfamily members.
This possibility will be pursued in future studies.
The coupling of the transcription and pre-mRNA processing machinery is clearly an important aspect of accurate gene expression. Our data provides important insight with regard to how the gene expression machinery is recruited into daughter nuclei at the end of mitosis. To our surprise, the gene expression machinery did not enter daughter nuclei in a stochastic manner but instead components entered in a reproducible sequence. It is possible that this sequential recruitment of proteins into daughter nuclei establishes favorable cues for transcription initiation within the context of the decondensing chromosomes. The formidable challenge will be to identify the critical signals that trigger this sequential recruitment.
| |
ACKNOWLEDGMENTS |
|---|
We thank members of the Spector laboratory for insightful discussions and suggestions and for critical review of the manuscript. We acknowledge D. Bregman, L. Davis, G. Dreyfuss, L. Freedman, A. Krainer, A. Krämer, D. Reinberg, S. Warren, X.-D. Fu, J. Manley, N. Hernandez, and W. van Venrooij for providing antibodies. We thank Jim Duffy for artwork and photography. D.L.S. is supported by National Institutes of Health/National Institute of General Medical Sciences 42694.
| |
FOOTNOTES |
|---|
Online version of this article contains video material for some
figures. Online version available at www.molbiolcell.org.
* Corresponding author. E-mail address: spector{at}cshl.org.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-10-0669. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-10-0669.
| |
REFERENCES |
|---|
|
|
|---|
family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins.
J. Biol. Chem.
275, 7950-7957